Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Voso

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALTL Arcaini, S Burcheri, A Rossi, et al.
The Pharmacogenomics Journal|December 6, 2017
MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidineG Visani, F Loscocco, A Ruzzo, et al.
Leukemia|October 6, 2023
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathwaysT Ottone, G Silvestrini, R Piazza, et al.
Leukemia|May 3, 2016
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapyL Cicconi, M Divona, C Ciardi, et al.
Leukemia Research|June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromesG Caocci, M T Voso, E Angelucci, et al.
Leukemia|March 22, 2017
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring SystemM G Della Porta, C H Jackson, E P Alessandrino, et al.
Leukemia|June 30, 2020
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDSA Kuendgen, M Nomdedeu, H Tuechler, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALTL Arcaini, S Burcheri, A Rossi, et al.
The Pharmacogenomics Journal|December 6, 2017
MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidineG Visani, F Loscocco, A Ruzzo, et al.
Leukemia|October 6, 2023
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathwaysT Ottone, G Silvestrini, R Piazza, et al.
Leukemia|May 3, 2016
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapyL Cicconi, M Divona, C Ciardi, et al.
Leukemia Research|June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromesG Caocci, M T Voso, E Angelucci, et al.
Leukemia|March 22, 2017
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring SystemM G Della Porta, C H Jackson, E P Alessandrino, et al.
Leukemia|June 30, 2020
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDSA Kuendgen, M Nomdedeu, H Tuechler, et al.
Pageof 6